
Gene2info, established in Boston in 2017, aims to improve human health and life quality through bioinformatics innovations by restructuring the journey from genes to information, leveraging the possibilities of genomic science. The company offers an end-to-end solution for the rapid diagnosis of rare diseases through genetic testing, covering all stages from biological sample transfer to genetic analysis report generation. Their solution includes disease-specific diagnostic kits and a proprietary, AI-powered bioinformatics algorithm (Gene2Var) for accurate and user-friendly genetic data analysis. Gene2info is positioned to significantly increase the diagnosis rate of rare diseases by providing innovative solutions for identifying genetic variations, ultimately enhancing patients' quality of life.

Gene2info, established in Boston in 2017, aims to improve human health and life quality through bioinformatics innovations by restructuring the journey from genes to information, leveraging the possibilities of genomic science. The company offers an end-to-end solution for the rapid diagnosis of rare diseases through genetic testing, covering all stages from biological sample transfer to genetic analysis report generation. Their solution includes disease-specific diagnostic kits and a proprietary, AI-powered bioinformatics algorithm (Gene2Var) for accurate and user-friendly genetic data analysis. Gene2info is positioned to significantly increase the diagnosis rate of rare diseases by providing innovative solutions for identifying genetic variations, ultimately enhancing patients' quality of life.